Fosravuconazole to treat severe onychomycosis in the elderly

Fosravuconazole is a novel oral antifungal drug developed in Japan and used to treat tinea unguium since 2018. Its excellent oral absorbability and systemic bioavailability has enabled short‐duration therapy of 3 months. Furthermore, no concomitant drugs are contraindicated due to the presence of th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of dermatology 2021-02, Vol.48 (2), p.228-231
Hauptverfasser:	Noguchi, Hiromitsu, Matsumoto, Tadahiko, Kimura, Utako, Hiruma, Masataro, Kano, Rui, Kubo, Masahide, Fukushima, Satoshi, Ihn, Hironobu
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antifungal agents Antifungal Agents - therapeutic use Bioavailability Cytochrome P450 Fingers & toes fosravuconazole Fungal infections Humans Japan Nails Older people Onychomycosis Onychomycosis - drug therapy Polypharmacy ravuconazole Skin diseases Tinea tinea unguium
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!